[1]
W. Prasartritha, S. Sukavatcharin, and B. Tipsuriyaporn, “Intravitreal Ranibizumab Treatment for Non-Proliferative Idiopathic Macular Telangiectasia”, Rama Med J, vol. 40, no. 3, pp. 38-47, Sep. 2017.